• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌具有筛状结构且 Gleason 评分为 4 分的情况下,筛状结构大小、比例和导管内癌对 Gleason 评分 7 的预后价值。

Prognostic value of cribriform size, percentage, and intraductal carcinoma in Gleason score 7 prostate cancer with cribriform Gleason pattern 4.

机构信息

Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

出版信息

Hum Pathol. 2021 Dec;118:18-29. doi: 10.1016/j.humpath.2021.09.005. Epub 2021 Sep 17.

DOI:10.1016/j.humpath.2021.09.005
PMID:34543668
Abstract

Cribriform Gleason pattern 4 (CGP4) is an indicator of poor prognosis in Gleason Score 7 prostate cancer; however, the significance of the size and percentage of this pattern and the presence of concomitant intraductal carcinoma (IDC) in these patients is unclear. To study the significance of these parameters in radical prostatectomy specimens, 165 cases with CGP4 were identified and reviewed (2017-2019). The size and percentage cribriform pattern and presence of IDC were noted and correlated with adverse pathological features and biochemical recurrence (BCR)-free survival. On review, 156 cases had CGP4 (Grade Group 2: 87 and Grade Group 3: 69). Large cribriform pattern and cribriform percentage of >20% showed significant association with extraprostatic extension, surgical margin positivity, and presence of IDC, whereas the presence of IDC was associated with all the analyzed adverse pathological features. BCR was seen in 22 of 111 (20%) patients after a median follow-up of 11 months, and of these, 21 had large cribriform pattern. On univariate analysis, all parameters had significant predictive values for BCR-free survival except for tertiary Gleason pattern 5. On multivariate analysis, while >20% cribriform pattern was trending to be an independent predictor, only lymphovascular invasion was statistically significant. Large cribriform pattern, >20% cribriform, and presence of IDC are additional pathologic parameters of potential value in identifying patients with high risk for early BCR.

摘要

筛状 Gleason 模式 4(CGP4)是 Gleason 评分 7 前列腺癌预后不良的指标;然而,这种模式的大小和百分比以及同时存在的导管内癌(IDC)在这些患者中的意义尚不清楚。为了研究这些参数在根治性前列腺切除标本中的意义,我们鉴定并回顾了 165 例有 CGP4 的病例(2017-2019 年)。记录了筛状模式的大小和百分比以及 IDC 的存在,并将其与不良病理特征和生化复发(BCR)无复发生存相关联。回顾性分析显示,156 例有 CGP4(G 分组 2:87 例,G 分组 3:69 例)。大筛状模式和筛状百分比>20%与前列腺外延伸、手术切缘阳性和 IDC 的存在有显著相关性,而 IDC 的存在与所有分析的不良病理特征均有关。在中位随访 11 个月后,111 例患者中有 22 例(20%)发生 BCR,其中 21 例有大筛状模式。在单因素分析中,所有参数对 BCR 无复发生存均有显著预测价值,除三级 Gleason 模式 5 外。多因素分析显示,虽然>20%的筛状模式有成为独立预测因子的趋势,但只有血管淋巴管侵犯具有统计学意义。大筛状模式、>20%筛状和 IDC 的存在是识别早期 BCR 高危患者的潜在有价值的附加病理参数。

相似文献

1
Prognostic value of cribriform size, percentage, and intraductal carcinoma in Gleason score 7 prostate cancer with cribriform Gleason pattern 4.前列腺癌具有筛状结构且 Gleason 评分为 4 分的情况下,筛状结构大小、比例和导管内癌对 Gleason 评分 7 的预后价值。
Hum Pathol. 2021 Dec;118:18-29. doi: 10.1016/j.humpath.2021.09.005. Epub 2021 Sep 17.
2
Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients.筛状结构在预测 2 级前列腺癌患者的结局方面优于 Gleason 模式 4 百分比和三级 Gleason 模式 5。
Histopathology. 2022 Feb;80(3):558-565. doi: 10.1111/his.14590. Epub 2021 Dec 14.
3
Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.前列腺导管内增生性病变的临床病理分析:前列腺导管内癌、高级别前列腺上皮内瘤变和非典型筛状病变。
Hum Pathol. 2014 Aug;45(8):1572-81. doi: 10.1016/j.humpath.2014.03.011. Epub 2014 Apr 12.
4
Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.大筛状生长模式可识别出 ISUP 分级 2 级前列腺癌,其具有高复发和转移风险。
Mod Pathol. 2019 Jan;32(1):139-146. doi: 10.1038/s41379-018-0157-9. Epub 2018 Oct 22.
5
Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.前列腺非典型导管筛状增生具有与前列腺导管癌相似的分子和临床病理特征。
Am J Surg Pathol. 2017 Apr;41(4):550-556. doi: 10.1097/PAS.0000000000000794.
6
Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4.膨胀型筛状 Gleason 模式 4 与肾小球样 Gleason 模式 4 相比,具有侵袭性的组织病理学和分子特征,以及更高的生化失败风险。
Prostate. 2020 May;80(8):653-659. doi: 10.1002/pros.23977. Epub 2020 Mar 27.
7
Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance.前列腺穿刺活检中的导管内癌:组织学特征及临床意义。
Mod Pathol. 2006 Dec;19(12):1528-35. doi: 10.1038/modpathol.3800702. Epub 2006 Sep 15.
8
Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.同时性或异时性转移性疾病的 2 级前列腺切除术标本中不良病理特征的发生率。
Prostate. 2022 Feb;82(3):345-351. doi: 10.1002/pros.24279. Epub 2021 Dec 8.
9
Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.前列腺导管内癌的异质性临床病理特征:“前体样”与“普通型”病变的比较
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2518-26. eCollection 2014.
10
GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture.GBX2 甲基化是一种新的预后生物标志物,可改善对非导管内癌和筛状结构的前列腺癌患者生化复发的预测。
Eur Urol Oncol. 2019 May;2(3):231-238. doi: 10.1016/j.euo.2018.08.003. Epub 2018 Sep 1.

引用本文的文献

1
Beyond Gleason grading: MRI radiomics to differentiate cribriform growth from non-cribriform growth in prostate cancer men.超越Gleason分级:MRI影像组学用于区分前列腺癌患者筛状生长与非筛状生长
MAGMA. 2025 Apr 29. doi: 10.1007/s10334-025-01251-5.
2
Association of Lymphovascular Invasion with Biochemical Recurrence and Adverse Pathological Characteristics of Prostate Cancer: A Systematic Review and Meta-analysis.淋巴管侵犯与前列腺癌生化复发及不良病理特征的关联:一项系统评价与Meta分析
Eur Urol Open Sci. 2024 Oct 8;69:112-126. doi: 10.1016/j.euros.2024.09.007. eCollection 2024 Nov.
3
Nomogram-based prognostic model construction for progression to castration-resistant prostate cancer in patients with high tumor burden and osseous metastatic prostate cancer.
基于列线图的高肿瘤负荷和骨转移前列腺癌患者进展为去势抵抗性前列腺癌的预后模型构建
Am J Cancer Res. 2024 Sep 15;14(9):4459-4471. doi: 10.62347/CWOS3653. eCollection 2024.
4
Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects.前列腺癌的组织病理学评估和分级:当前的问题和关键方面。
Asian J Androl. 2024 Nov 1;26(6):575-581. doi: 10.4103/aja202440. Epub 2024 Sep 10.
5
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage.前列腺腺癌中,预测转移风险的不良病理学(不利组织学)的优化定义建议,与分级分组和病理分期无关。
Histopathology. 2024 Oct;85(4):598-613. doi: 10.1111/his.15231. Epub 2024 Jun 3.
6
Significance of the cribriform morphology area ratio for biochemical recurrence in Gleason score 4 + 4 prostate cancer patients following robot-assisted radical prostatectomy.机器人辅助前列腺根治术后格里森评分 4+4 前列腺癌患者的筛状形态区域比与生化复发的关系。
Cancer Med. 2024 Mar;13(5):e7086. doi: 10.1002/cam4.7086.
7
Quantification of Gleason Pattern 4 at MRI-Guided Biopsy to Predict Adverse Pathology at Radical Prostatectomy in Intermediate-Risk Prostate Cancer Patients.磁共振成像引导下活检时对Gleason 4级模式进行定量分析,以预测中危前列腺癌患者根治性前列腺切除术后的不良病理结果
Cancers (Basel). 2023 Nov 17;15(22):5462. doi: 10.3390/cancers15225462.
8
Ki67 and the apparent diffusion coefficient in postoperative prostate cancer with endocrine therapy.Ki67与内分泌治疗后前列腺癌的表观扩散系数
Front Surg. 2023 Apr 5;10:1140883. doi: 10.3389/fsurg.2023.1140883. eCollection 2023.
9
The highest percentage of Gleason Pattern 4 is a predictor in intermediate-risk prostate cancer.Gleason 4级所占的最高比例是中危前列腺癌的一个预测指标。
BJUI Compass. 2022 Oct 17;4(2):234-240. doi: 10.1002/bco2.195. eCollection 2023 Mar.
10
Current conundrums with cribriform prostate cancer.筛状前列腺癌的当前难题
Histopathology. 2022 Jun;80(7):1038-1040. doi: 10.1111/his.14665.